EG BioMed’s innovative technology opens a new era of accurate detection of breast cancer!

2022/03/31

Note, according to the statistics of the Ministry of Health and Welfare, “breast cancer” is the number one cancer among women in my country, and the incidence rate is also rising year by year. At present, breast cancer in Taiwan has two warning signs of “invincible and younger”. It can be said to be the number one of women’s health. Enemy!

In order to reduce the threat of breast cancer to the health of Chinese people, “early detection and early treatment” #breastcancerscreening is an important strategy!

Through the Biotechnology Center, the Bureau of Industry implements the “Precision Medical Strategy Value-Added International Promotion Plan” to assist “EG BioMed-Taipei Medical University spin-off start-up company” to develop innovative “blood testing technology”, which can be used more easily and quickly and accurate way to detect breast cancer early.

Through the technology of blood detection of cancer and the analysis of medical big data, Ai Liji Biomedical can accurately screen out specific cancer biomarkers, provide doctors and the public with information about cancer risks, and open a new era of accurate detection of breast cancer.

Remind all female friends that the 5-year survival rate of early breast cancer exceeds 90%, so you should be vigilant and develop the habit of self-examination and regular screening from an early age to achieve the effect of early detection and early treatment.

Leave a Reply